Thrombosis and coagulation: Operative management of the anticoagulated patient

Surgical Clinics of North America

Volumn 85, Issue 6, 2005, Pages 1179-1189

  Owens, Christopher D ^a   Belkin, Mike ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ARGATROBAN; CLOPIDOGREL; HEPARIN; HIRUDIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE; THROMBIN INHIBITOR; WARFARIN; XIMELAGATRAN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING; BLOOD CLOTTING; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART VALVE; HUMAN; MEDICAL PRACTICE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN NECROSIS; SURGICAL TECHNIQUE; THROMBOEMBOLISM; THROMBOSIS; VEIN THROMBOSIS;

ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; SURGICAL PROCEDURES, OPERATIVE; THROMBOSIS; TREATMENT OUTCOME;

EID: 28544446411     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2005.09.008     Document Type: Review

References (41)

1. E.W. Davie, and O.D. Ratnoff Waterfall sequence for intrinsic blood clotting Science 145 1964 1310 1312
2. D.M. Monroe, M. Hoffman, and H.R. Roberts Platelets and thrombin generation Arterioscler Thromb Vasc Biol 22 9 2002 1381 1389
3. B. Dahlback Blood coagulation Lancet 355 9215 2000 1627 1632
4. D.T. Mangano Aspirin and mortality from coronary bypass surgery N Engl J Med 347 17 2002 1309 1317
5. L.J. Dacey Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients Ann Thorac Surg 70 6 2000 1986 1990
6. D.T. Neilipovitz, G.L. Bryson, and G. Nichol The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis Anesth Analg 93 3 2001 573 580
7. P.D. Stein Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 Suppl 2004 600S 608S
8. G. Hollopeter Identification of the platelet ADP receptor targeted by antithrombotic drugs Nature 409 6817 2001 202 207
9. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 9038 1996 1329 1339
10. J. Fajadet Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial Circulation 111 8 2005 1040 1044
11. E.M. Antman ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) Circulation 110 5 2004 588 636
12. J. Hirsh American Heart Association/American College of Cardiology Foundation guide to warfarin therapy Circulation 107 12 2003 1692 1711
13. K. Suzuki Protein S is essential for the activated protein C-catalyzed inactivation of platelet-associated factor Va J Biochem (Tokyo) 96 2 1984 455 460
14. A.W. Broekmans Protein C and the development of skin necrosis during anticoagulant therapy Thromb Haemost 49 3 1983 251
15. J. Hirsh Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range Chest 119 1 Suppl 2001 8S 21S
16. R.H. White Temporary discontinuation of warfarin therapy: changes in the international normalized ratio Ann Intern Med 122 1 1995 40 42
17. U. Genewein Rebound after cessation of oral anticoagulant therapy: the biochemical evidence Br J Haematol 92 2 1996 479 485
18. C. Kearon, and J. Hirsh Management of anticoagulation before and after elective surgery N Engl J Med 336 21 1997 1506 1511
19. B. Sorensen Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects Blood Coagul Fibrinolysis 14 5 2003 469 477
20. J. Ansell The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 Suppl 2004 204S 233S
21. J. Choay Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity Biochem Biophys Res Commun 116 2 1983 492 499
22. J. Hirsh Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety Chest 119 1 Suppl 2001 64S 94S
23. M. Laposata College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban Arch Pathol Lab Med 122 9 1998 799 807
24. H.K. Nieuwenhuis Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin Blood 78 9 1991 2337 2343
25. J.D. Douketis, J.A. Johnson, and A.G. Turpie Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen Arch Intern Med 164 12 2004 1319 1326
26. M. Di Nisio, S. Middeldorp, and H. Büller Drug Therapy. Direct thrombin inhibitors N Engl J Med 353 2005 1028 1040
27. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 13 1994 1449 1457
28. H.J. Lin Stroke severity in atrial fibrillation. The Framingham Study Stroke 27 10 1996 1760 1764
29. H.S. Jorgensen Acute stroke with atrial fibrillation. The Copenhagen Stroke Study Stroke 27 10 1996 1765 1769
30. EAFT (European Atrial Fibrillation Trial) Study Group Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke Lancet 342 8882 1993 1255 1262
31. The American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery Chest 128 Suppl 2005 1S 64S
32. C. Flanc, V.V. Kakkar, and M.B. Clarke The detection of venous thrombosis of the legs using 125-I-labelled fibrinogen Br J Surg 55 10 1968 742 747
33. M.T. Metzdorff Thrombosis of mechanical cardiac valves: a qualitative comparison of the silastic ball valve and the tilting disc valve J Am Coll Cardiol 4 1 1984 50 53
34. L.H. Edmunds Jr. Thromboembolic complications of current cardiac valvular prostheses Ann Thorac Surg 34 1 1982 96 106
35. W. Vongpatanasin, L.D. Hillis, and R.A. Lange Prosthetic heart valves N Engl J Med 335 6 1996 407 416
36. T. Gherli Comparing warfarin with aspirin after biological aortic valve replacement. A prospective study Circulation 110 5 2004 496 500
37. The seventh ACCP conference on antithrombotic and thrombolytic therapy: evidence-based guidelines Chest 126 suppl 2004 163S 696S
38. C.K. Mok Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial Circulation 72 5 1985 1059 1063
39. J.D. Douketis Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery Chest 116 5 1999 1240 1246
40. D.N. Salem, P.D. Stein, and A. Al-Ahmad Antithrombotic therapy in valvular heart disease - native and prosthetic: the seventh AACP conference on antithrombotic and thrombolytic therapy Chest 126 2004 457S 482S
41. W.H. Geerts, G.F. Pineo, and J.A. Heit Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombotic therapy Chest 126 2004 338S 400S